Laboratory Information System Market Size and Share

Laboratory Information System Market Analysis by Mordor Intelligence
The laboratory information system market size is expected to reach USD 2.65 billion in 2026 and is forecast to reach USD 4.90 billion by 2031, reflecting a 13.08% CAGR during the period. Demand is accelerating as hospital and reference laboratories retire legacy software, adopt cloud deployments, and prepare for stringent HL7 FHIR interoperability deadlines. Laboratories are also scaling digital pathology and next-generation sequencing programs that generate terabytes of data daily, which favors platforms offering elastic storage and embedded AI analytics. Vendors with HIPAA-eligible and GDPR-compliant cloud regions are pulling ahead, while edge-computing appliances extend LIS connectivity to rural sites with intermittent bandwidth. Cybersecurity outlays and a shortage of LIS-literate informaticians temper adoption but have simultaneously strengthened the services opportunity, as laboratories outsource security patching and regulatory monitoring to vendors.
Key Report Takeaways
- By component, services captured 60.05% of the laboratory information system market share in 2025 and are projected to expand at a 13.99% CAGR through 2031.
- By mode of delivery, cloud-based deployments held 54.32% of the laboratory information system market size in 2025 and are forecast to grow 14.12% annually to 2031.
- By laboratory type, anatomic pathology commanded a 14.33% CAGR between 2026-2031, the fastest among all segments.
- By end user, standalone laboratories recorded a 13.76% CAGR from 2026-2031, outpacing hospitals and clinics.
- By geography, North America led with a 43.57% market share in the laboratory information system market in 2025; the Asia-Pacific region recorded the fastest 14.42% CAGR through 2031.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.
Global Laboratory Information System Market Trends and Insights
Drivers Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising global diagnostic testing volumes | +2.2% | Global, with APAC and MEA outpacing mature markets | Medium term (2-4 years) |
| Rapid scale-up of biobank networks | +1.2% | North America & EU core, expanding to APAC | Long term (≥4 years) |
| Cloud/SaaS LIS lowering capital outlays | +1.8% | Global, strongest in capital-constrained regions | Short term (≤2 years) |
| AI-powered workflow automation modules | +1.5% | North America & EU early adopters, APAC following | Medium term (2-4 years) |
| Mandatory LIS-EHR interoperability | +2.0% | North America & EU regulatory mandate zones | Short term (≤2 years) |
| Edge-LIS micro-appliances | +0.6% | APAC rural, Sub-Saharan Africa, Latin America | Long term (≥4 years) |
| Source: Mordor Intelligence | |||
Rising Global Diagnostic Testing Volumes
Worldwide specimen volumes are climbing 6-8% annually as aging populations, chronic disease screening, and public-health mandates stretch manual workflows. Europe’s largest chain, SYNLAB, processed more than 600 million tests in 2024 and cut pre-analytical errors by 18% after automating triage through its. Next-generation sequencing runs now generate gigabytes of data per patient, compelling laboratories to deploy bioinformatics-ready LIS modules. In India, Dr. Lal PathLabs manages logistics for 2,500 laboratories and 4,000 collection centers through a centralized cloud LIS that supports 12-15% annual volume growth. Rising throughput is also boosting demand for AI auto-verification that trims routine chemistry turnaround times by up to 30%.
Rapid Scale-Up of Biobank Networks
Precision-medicine initiatives are spawning national biobanks that require long-term specimen tracking, consent management, and multi-omics linkage. The UK Biobank finished whole-genome sequencing for 500,000 participants in 2024, a milestone that depends on federated LIS query capabilities [1]UK Biobank, “Whole-Genome Sequencing Completion,” ukbiobank.ac.uk. Europe’s Genome of Europe project and the U.S. All of Us Program rely on cloud-native LIS layers that meet ISO 20387 standards while supporting GDPR-compliant pseudonymization. SaaS LIS vendors offering pre-validated chain-of-custody modules are therefore seeing strong inbound interest from academic consortia and regional research centers.
Cloud/SaaS LIS Lowering Capital Outlays
Cloud platforms eliminate USD 200,000-500,000 in server purchases and allow laboratories to activate production environments in weeks. AWS HealthLake, launched in 2024, provides HIPAA-eligible FHIR data stores with consumption pricing that lowers five-year TCO by 30-40%. Microsoft Azure Health Data Services starts at USD 0.10 per gigabyte stored, appealing to low-volume specialty labs [2]Microsoft, “Azure Health Data Services,” microsoft.com. Google Cloud’s Healthcare API ships with HL7 v2.x and FHIR connectors that reduce middleware costs.
AI-Powered Workflow Automation Modules
FDA-cleared systems such as PathAI’s AISight and Paige.AI’s FullFocus embed deep-learning algorithms that flag high-risk slides, cutting pathologist review time by 25%. Google Health research published in 2024 showed AI-assisted cytology improved cervical-cancer sensitivity to 94%. These advances push laboratories to upgrade LIS architectures so AI outputs can write directly to patient records and drive predictive maintenance on analyzers.
Restraints Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High total cost of ownership | −1.1% | Global, most acute in small-to-mid-size independent labs | Medium term (2-4 years) |
| Escalating cybersecurity liabilities | −1.0% | North America & EU regulatory zones, spreading globally | Short term (≤2 years) |
| Shortage of LIS-literate informaticians | −0.7% | Global, particularly acute in North America & EU | Medium term (2-4 years) |
| Volatile open-API standards | −0.5% | Global, affecting multi-vendor integration projects | Long term (≥4 years) |
| Source: Mordor Intelligence | |||
High Total Cost of Ownership
Mid-size laboratories with 100-500 daily accessions spend USD 150,000-400,000 per year on licenses, interfaces, and IT support. Per-analyzer interface fees of USD 5,000-15,000 erode margins, while cloud subscription costs scale with data retention. Consulting for FHIR mapping or custom reports can exceed USD 200 per hour, and training now represents 20-25% of go-live budgets.
Escalating Cybersecurity & HIPAA/GDPR Liabilities
Ransomware assaults surged to 725 reported breaches in U.S. healthcare facilities during 2023, with the February 2024 Change Healthcare attack alone disrupting claims worth USD 6.3 billion. Laboratories must now budget for intrusion detection, zero-trust network designs, and 24/7 security operations centers. The U.S. HHS framework released in December 2023 proposes mandatory cyber practices, and GDPR fines in Europe climb to 4% of annual revenue for non-compliance. These costs divert funds from functional upgrades and lengthen procurement cycles, particularly for cloud deployments that trigger strict data-sovereignty reviews.
Segment Analysis
By Component: Services Outpace Software as Integration Complexity Escalates
Services contributed 60.05% of the laboratory information system market in 2025, and their revenue is projected to rise 13.99% annually through 2031. The laboratory information system market size for services is growing because laboratories require FHIR mapping, AI validation, and multi-site cloud orchestration. SaaS platforms are eroding perpetual-license software sales, but longer implementation cycles push consulting and managed-services demand.
Managed support contracts now bundle security patching, disaster recovery, and accreditation reporting, converting previously discretionary spend into recurring fees. Vendors offering pre-validated templates win faster deals, while training engagements aligned with ISO 15189 audits keep consulting pipelines full.

Note: Segment shares of all individual segments available upon report purchase
By Mode of Delivery: Cloud-Based Dominance Reflects Capital Efficiency and Regulatory Agility
Cloud models controlled 54.32% of the laboratory information system market share in 2025. Elastic infrastructure lets laboratories scale influenza testing surges without over-provisioning hardware, and built-in FHIR endpoints simplify compliance. The laboratory information system market size tied to on-premise installations is shrinking as server refresh and cybersecurity costs climb.
Hybrid deployments remain relevant where data-localization laws restrict cross-border transfer, allowing sensitive genomic data to stay on-site while administrative modules run in the cloud. Vendors secure a competitive advantage by offering HIPAA Business Associate Agreements and country-specific GDPR hosting zones.
By Laboratory Type: Anatomic Pathology Labs Lead Growth on Digital Pathology Integration
Anatomic pathology is the fastest-growing laboratory cohort, posting a 14.33% CAGR as whole-slide imaging and AI tumor detection gain clinical acceptance. The laboratory information system market size for anatomic pathology benefits from multi-gigabyte image storage and remote consultation workflows, compelling vendors to optimize for DICOM and high-bandwidth streaming.
Clinical pathology retained the largest revenue base with 38.57% share in 2025, but its incremental growth trails digital pathology’s momentum. Molecular diagnostics laboratories also require deep bioinformatics hooks, adding pressure on vendors to ship variant-calling pipelines natively inside the LIS.

Note: Segment shares of all individual segments available upon report purchase
By End User: Laboratories Segment Outpaces Hospitals as Consolidation Accelerates
Standalone laboratories are expanding at 13.76% CAGR as diagnostic chains acquire regional players and deploy centralized cloud LIS across thousands of collection points. Hospitals and clinics still hold 54.87% share, yet replacement cycles are lengthening to 7-10 years, slowing unit sales.
Academic and research institutes adopt federated LIS to support multi-center trials, while value-based care contracts push hospitals toward stewardship dashboards that curb redundant testing. The laboratory information system industry’s service providers now bundle analytics that flag inappropriate orders in real time.
Geography Analysis
North America accounted for 43.57% of 2025 revenue, reflecting high installed-base maturity and early regulatory triggers. The United States leads upgrades as laboratories race to meet the January 2027 FHIR mandate, while Canada’s provincial health authorities fund consolidated cloud rollouts to harmonize result sharing. Mexico shows steady gains as private diagnostic firms expand into secondary cities, though currency volatility tempers capital budgets.
Asia-Pacific is projected to post 14.42% CAGR, the fastest regional expansion in the laboratory information system market. India’s ISO 15189 accreditation drive and China’s Healthy China 2030 program are digitizing tertiary hospital labs [3]National Health Commission of China, “Healthy China 2030,” nhc.gov.cn. Diagnostic chains such as Dr. Lal PathLabs leverage cloud LIS to monitor 2,500 labs in real time, promoting standardized SOPs across tier-2 and tier-3 cities. Japan and Australia invest in national health information exchanges that embed LIS result feeds.
Europe enjoys stable uptake as the Health Data Space regulation mandates cross-border laboratory interoperability. Germany, with more than 1,800 hospital labs, leads cloud migration to comply with Medical Device Regulation software clauses. The United Kingdom consolidates pathology services into 29 regional networks that issue unified LIS tenders to cut costs and improve turnaround. France, Italy, and Spain follow similar digitization arcs, synchronized with phased EHDS deadlines through 2031.

Competitive Landscape
The laboratory information system market is moderately fragmented; the top five vendors hold the majority of revenue. Epic Systems and Oracle Health ride incumbent EHR footprints to bundle LIS modules, yet best-of-breed buyers prefer specialty depth. Clinisys, Soft Computer Consultants, and CompuGroup Medical embed predictive maintenance, AI validation, and turnkey FHIR APIs to shorten go-lives.
Cloud hyperscalers add pressure by launching LIS-as-a-Service blueprints on AWS, Azure, and Google Cloud, allowing mid-size labs to bypass traditional vendors. Equipment makers like Sysmex and Werfen now ship analyzers with native LIS layers, converting hardware channels into software gateways. Meanwhile, open-source projects such as OpenELIS gain traction in donor-funded programs where licensing budgets are tight.
Edge-LIS appliances, federated biobank modules, and AI-enabled digital pathology represent white-space niches. Vendors that secure ISO 15189 or CLIA-compliant certifications capitalize on laboratories’ need to pass audits quickly, and those offering managed compliance monitoring lock in annuity revenue.
Laboratory Information System Industry Leaders
Clinisys, Inc.
CompuGroup Medical SE & Co. KGaA
Epic Systems Corporation
Oracle Corporation
Sysmex Corporation
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- January 2025: QBench expanded its customer service offerings by rolling out a Premium Support tier designed to provide enhanced coverage for laboratories operating across different time zones
- July 2025: Titian Software and Labguru rebranded as Cenevo, combining automation and data-management portfolios.
- August 2024: Quest Diagnostics purchased LifeLabs for USD 985 million to strengthen its Canadian network.
Research Methodology Framework and Report Scope
Market Definitions and Key Coverage
Our study defines the laboratory information system (LIS) market as global revenue generated from software platforms and related services that handle sample accessioning, test ordering, result validation, and data exchange inside clinical, anatomic, and molecular pathology laboratories. The scope embraces on-premise, cloud, and hybrid deployments used by hospitals, independent labs, blood banks, and biobanks, and all values are expressed in constant 2025 USD.
Scope Exclusions: Solutions limited to research-only LIMS, electronic lab notebooks, middleware interface boxes, or hardware sales are out of scope.
Segmentation Overview
- By Component
- Software
- Stand-alone LIS
- Integrated LIS / EHR-centric
- SaaS LIS Platforms
- Services
- Implementation & Integration
- Maintenance & Support
- Training & Consulting
- Software
- By Mode of Delivery
- On-Premise
- Cloud-Based
- Hybrid
- By Laboratory Type
- Clinical Pathology Labs
- Anatomic Pathology Labs
- Molecular Diagnostics Labs
- Blood Banks & Biobanks
- Other Specialized Labs
- By End User
- Hospitals & Clinics
- Laboratories
- Academic & Research Institutes
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Detailed Research Methodology and Data Validation
Primary Research
Mordor analysts interview LIS administrators, pathologists, hospital IT directors, and regional integrators across North America, Europe, Asia-Pacific, Latin America, and the Middle East. These conversations refine average workstation counts, cloud migration speeds, refresh intervals, and discounting practices, closing gaps flagged during desk review.
Desk Research
We start by extracting test-volume trends, laboratory counts, and health-IT spending from tier-one public sources such as WHO, CDC, Eurostat, and OECD. Trade briefs from the College of American Pathologists and the European Federation of Clinical Chemistry reveal accreditation rates and digitization mandates, while 10-Ks of in-vitro diagnostic vendors clarify interface pricing. Patent analytics pulled through Questel highlight refresh cycles, and news wires on Dow Jones Factiva plus company records on D&B Hoovers track expansion moves. The sources listed illustrate key inputs; many additional documents underpin interim validations.
Market-Sizing & Forecasting
Our top-down build links global test volumes and lab density to typical LIS penetration and mean annual spend per workstation. Supplier roll-ups from sampled contracts act as a bottom-up checkpoint before results are reconciled. Key model drivers include inpatient test mix, interoperability deadlines, enterprise consolidation, cloud price erosion, and currency shifts. Multivariate regression coupled with scenario analysis extends each driver through 2030, while missing inputs are imputed from vetted regional analogs.
Data Validation & Update Cycle
Outputs pass two analyst reviews, then anomalies are screened against independent series such as healthcare IT outlays and pathology staffing ratios. Reports refresh annually, with unscheduled updates triggered by material events like landmark reimbursement changes.
Why Mordor's Laboratory Information System Baseline Earns Trust
Published estimates often diverge because firms adopt different functional scopes, deployment mixes, and refresh cadences. By clarifying these choices up front, we help buyers understand exactly what our 2025 figure represents.
Key gap drivers include whether LIMS revenues are blended, the aggressiveness of cloud price deflation, and whether service renewal fees are annualized or capitalized. Mordor reports only pure-play LIS revenue and applies realized ASP erosion captured from live bids, producing a realistic baseline.
Benchmark comparison
| Market Size | Anonymized source | Primary gap driver |
|---|---|---|
| USD 3.94 Bn (2025) | Mordor Intelligence | - |
| USD 2.18 Bn (2024) | Global Consultancy A | Omits enterprise-wide service contracts and specialty labs |
| USD 3.30 Bn (2024) | Trade Journal B | Blends LIMS with LIS and uses list prices |
| USD 2.73 Bn (2025) | Industry Association C | Applies conservative penetration ratios and older FX rates |
In sum, Mordor's disciplined scope choices, live pricing checks, and annual refresh cycle give decision-makers a transparent, balanced baseline that is traceable to verifiable laboratory metrics.
Key Questions Answered in the Report
How big is the Laboratory Information System Market?
The laboratory information system market size is USD 2.65 billion in 2026 and is projected to climb to USD 4.90 billion by 2031.
Which deployment model is growing fastest?
Cloud-based solutions lead growth at a 14.12% CAGR because they cut capital outlays and simplify HL7 FHIR compliance.
Why are services revenue outpacing software sales?
Laboratories need FHIR mapping, AI validation, and security monitoring, which extend implementation timelines and fuel double-digit services growth.
Which laboratory type offers the highest growth opportunity?
Anatomic pathology labs, propelled by digital slide imaging and AI tumor detection, are expanding at 14.33% annually through 2031.
What is the main regulatory driver in the United States?
CMS requires all Medicare-participating laboratories to expose HL7 FHIR R4 APIs by January 2027, forcing legacy system upgrades.
How fragmented is vendor competition?
Moderate fragmentation persists, with the top five suppliers holding nearly halfcombined share.




